Balchem Corp (BCPC) valuation
Balchem P/E ratio history
Balchem trades at 32.0 times its earnings over the last twelve months and 27.2 times the earnings analysts expect over the next twelve. At its last 10 fiscal year ends its P/E ranged from 28.9 (year to Dec 2017) to 57.2 (year to Dec 2021), with a median of 41.4.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $153.36 | $4.75 | 32.3 | 29.7 |
| Dec 31, 2024 | $163.00 | $3.93 | 41.5 | 34.3 |
| Dec 31, 2023 | $148.75 | $3.35 | 44.4 | — |
| Dec 31, 2022 | $122.11 | $3.25 | 37.6 | 31.7 |
| Dec 31, 2021 | $168.60 | $2.95 | 57.2 | 47.1 |
| Dec 31, 2020 | $115.22 | $2.60 | 44.3 | — |
| Dec 31, 2019 | $101.63 | $2.46 | 41.3 | — |
| Dec 31, 2018 | $78.35 | $2.43 | 32.2 | — |
| Dec 31, 2017 | $80.60 | $2.79 | 28.9 | — |
| Dec 31, 2016 | $83.92 | $1.75 | 48.0 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Balchem valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| BalchemBCPC | $5.42B | 32.0 | 27.2 | 4.9 |
| Mosaic Company (The)MOS | $5.84B | — | 20.2 | 0.5 |
| Sensient TechnologiesSXT | $5.01B | 31.7 | 25.6 | 2.9 |
| MaterionMTRN | $4.62B | 51.9 | 28.7 | 2.2 |
| Perimeter SolutionsPRM | $4.58B | — | 16.5 | 6.1 |
| Warrior Met CoalHCC | $4.54B | 20.7 | 12.1 | 2.7 |
| MP MaterialsMP | $7.04B | — | 103.9 | 16.9 |
| Commercial MetalsCMC | $7.08B | 10.9 | 9.4 | 0.8 |
| AvientAVNT | $3.93B | 23.2 | 12.8 | 1.2 |
| Peer median | 23.2 | 18.4 | 2.5 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: BCPC financials · BCPC returns
No forecast, no recommendation. This page describes Balchem Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.